Harnessing the power of an advanced in vitro 3D liver model and error-corrected duplex sequencing for the detection of mutational signatures
Mutagenesis · 2026
DOI: 10.1093/mutage/geaf015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mutagenesis, 2026. Verfasst von Gillian E Conway und 10 weiteren Autor:innen. Beteiligte Einrichtung: In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, United Kingdom. Hauptthemen laut MEDLINE: Liver, High-Throughput Nucleotide Sequencing, Mutation, Point Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Programme Hubert Curien Alliance, European Union.
Abstract (Originalsprache)
Genotoxicity testing plays a crucial role in evaluating the hazards posed by various chemicals. Traditional methods, such as the Ames test, mammalian cell mutation assays and the transgenic rodent assay have certain limitations, including laborious procedures and/or reliance on animal models. The aim of this study was to determine the potential of using error-corrected next-generation sequencing, specifically duplex sequencing (DS), as an alternative method for the detection of point mutations in conjunction with advanced in vitro models. This study establishes an easy to use, adaptable in vitro 3D HepG2 model, that shows good viability and liver functionality over 14 days. 3D HepG2 spheroids were exposed to aristolochic acid in a repeated dose regime over 4 days. This was shown to significantly induce micronucleus formation, indicative of fixed DNA damage, in a dose-dependent fashion. DS coupled with mutational signature analyses revealed a predominant treatment-specific T:A > A:T-enriched mutational signature explained by COSMIC signature SBS22 derived from human cancers associated with aristolochic acid exposure. De novo extraction provided a stable signature, of which > 40% were unambiguously explained by SBS22. These results demonstrate that the presented 3D HepG2 spheroid model is appropriate for assessing chemically induced fixed DNA damage. Additionally, we provide evidence that DS applied to the studied in vitro 3D model has the capacity to reveal specific mutational signatures of mutagenic exposures. The modern integrative approach will improve the understanding of mechanisms of carcinogenesis related to chemical exposures by providing a cost-effective and efficient means to assess genotoxicity and mutagenicity. With the inclusion of mutational signature analyses, this approach would see a reduction in reliance on animal models and the enhancement of hazard assessment accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales SA2 8PP, United Kingdom.
- Epigenomics and Mechanisms Branch, International Agency for Research on Cancer, World Health Organization, Lyon 69007, France.
- Cancer Research Center, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, University Claude Bernard Lyon 1, Lyon 69008, France.
ORCID-Profile: Gillian E Conway, Jiri Zavadil, Shareen H Doak
Förderung
- World Health Organization
- Programme Hubert Curien Alliance
- European Union
- United Kingdom Environmental Mutagen Society (UKEMS)
Zitieren
APA
Conway, G. E., Chavanel, B., Virard, F., Shah, U. K., Burgum, M. J., Evans, S. J., Korenjak, M., Thomas, L. E., Jenkins, G. J., Zavadil, J., & Doak, S. H. (2026). Harnessing the power of an advanced in vitro 3D liver model and error-corrected duplex sequencing for the detection of mutational signatures. Mutagenesis. https://doi.org/10.1093/mutage/geaf015
Vancouver
Conway GE, Chavanel B, Virard F, Shah UK, Burgum MJ, Evans SJ, et al. Harnessing the power of an advanced in vitro 3D liver model and error-corrected duplex sequencing for the detection of mutational signatures. Mutagenesis. 2026. doi:10.1093/mutage/geaf015
BibTeX
@article{Conway2026,
author = {Conway, Gillian E and Chavanel, Bérénice and Virard, François and Shah, Ume-Kulsoom and Burgum, Michael J and Evans, Stephen J and Korenjak, Michael and Thomas, Laura E and Jenkins, Gareth J and Zavadil, Jiri and Doak, Shareen H},
title = {Harnessing the power of an advanced in vitro 3D liver model and error-corrected duplex sequencing for the detection of mutational signatures},
journal = {Mutagenesis},
year = {2026},
doi = {10.1093/mutage/geaf015}
}
EUVIMED